Citadel Advisors’s Albireo Pharma Inc ALBO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-25,500
| Closed | -$551K | – | 16087 |
|
|
2022
Q4 | $551K | Sell |
25,500
-6,200
| -20% | -$131K | ﹤0.01% | 8038 |
|
|
2022
Q3 | $614K | Buy |
31,700
+7,100
| +29% | +$147K | ﹤0.01% | 8018 |
|
|
2022
Q2 | $489K | Buy |
24,600
+1,700
| +7% | +$44.8K | ﹤0.01% | 8708 |
|
|
2022
Q1 | $683K | Sell |
22,900
-12,800
| -36% | -$375K | ﹤0.01% | 8636 |
|
|
2021
Q4 | $831K | Buy |
35,700
+3,500
| +11% | +$93.1K | ﹤0.01% | 8394 |
|
|
2021
Q3 | $1M | Buy |
32,200
+21,900
| +213% | +$678K | ﹤0.01% | 8141 |
|
|
2021
Q2 | $362K | Sell |
10,300
-7,800
| -43% | -$254K | ﹤0.01% | 10815 |
|
|
2021
Q1 | $638K | Sell |
18,100
-3,700
| -17% | -$137K | ﹤0.01% | 9145 |
|
|
2020
Q4 | $818K | Sell |
21,800
-4,800
| -18% | -$175K | ﹤0.01% | 7213 |
|
|
2020
Q3 | $888K | Buy |
+26,600
| New | +$775K | ﹤0.01% | 6249 |
|
|
2016
Q4 | – | Sell |
-690
| Closed | -$9K | – | 8031 |
|
|
2016
Q3 | $9K | Sell |
690
-1,900
| -73% | -$22.4K | ﹤0.01% | 7148 |
|
|
2016
Q2 | $24K | Sell |
2,590
-237
| -8% | -$2.61K | ﹤0.01% | 6563 |
|
|
2016
Q1 | $28K | Buy |
2,827
+2,414
| +585% | +$21.5K | ﹤0.01% | 6392 |
|
|
2015
Q4 | $4K | Hold |
413
| – | – | ﹤0.01% | 8500 |
|
|
2015
Q3 | $5K | Sell |
413
-54
| -12% | -$1.36K | ﹤0.01% | 8645 |
|
|
2015
Q2 | $14K | Buy |
467
+80
| +21% | +$2.69K | ﹤0.01% | 8313 |
|
|
2015
Q1 | $14K | Sell |
387
-33
| -8% | -$1.39K | ﹤0.01% | 8098 |
|
|
2014
Q4 | $17K | Buy |
420
+173
| +70% | +$7.59K | ﹤0.01% | 7924 |
|
|
2014
Q3 | $12K | Buy |
+247
| New | +$14.2K | ﹤0.01% | 7706 |
|
|
2014
Q2 | – | Sell |
-103
| Closed | -$8K | – | 8413 |
|
|
2014
Q1 | $8K | Sell |
103
-170
| -62% | -$15.5K | ﹤0.01% | 7580 |
|
|
2013
Q4 | $19K | Sell |
273
-864
| -76% | -$63.3K | ﹤0.01% | 6498 |
|
|
2013
Q3 | $107K | Buy |
1,137
+964
| +557% | +$126K | ﹤0.01% | 5307 |
|
|
2013
Q2 | $22K | Buy |
+173
| New | +$18K | ﹤0.01% | 6034 |
|
Other funds holding ALBO
Citadel Advisors's ALBO Position: Q1 2023 in Review
Citadel Advisors sold out of Albireo Pharma Inc (ALBO) in Q1 2023, closing a stake of 2,169 shares — an estimated $46.9K sold.
Citadel Advisors first reported a position in ALBO in Q2 2013 and held it in 24 quarters. The position peaked at $4.83M in Q3 2022. 3 funds tracked by Wall St. Rank hold ALBO as of Q1 2023.
- Citadel Advisors reported no remaining Albireo Pharma Inc position as of Q1 2023 after selling out during the quarter.
- Citadel Advisors sold 2,169 Albireo Pharma Inc shares in Q1 2023, an estimated $46.9K.
- Citadel Advisors first reported a position in Albireo Pharma Inc in Q2 2013 and held it in 24 quarters.
- Citadel Advisors's Albireo Pharma Inc position peaked at $4.83M in Q3 2022.
- 3 funds tracked by Wall St. Rank held Albireo Pharma Inc as of Q1 2023.
Based on Citadel Advisors's 13F filing for Q1 2023, filed 15 May 2023.